Polymyositis Completed Phase 2 / 3 Trials for Anakinra (DB00026)

IndicationStatusPhase
DBCOND0013509 (Polymyositis)Completed2 / 3
clinicaltrials.gov IdentifierTitlePurposeDrugs
NCT01165008Anakinra in MyositisTreatment